110 related articles for article (PubMed ID: 31469900)
21. Atezolizumab and Its Many Uses.
Saleh N; Copur MS
Oncology (Williston Park); 2019 Aug; 33(8):. PubMed ID: 31469902
[No Abstract] [Full Text] [Related]
22. Characterization of Myeloid-derived Suppressor Cells in a Patient With Lung Adenocarcinoma Undergoing Durvalumab Treatment: A Case Report.
Bertelli G; Trovato R; Ugel S; Bria E; Milella M; Bronte V; Pilotto S
Clin Lung Cancer; 2019 Jul; 20(4):e514-e516. PubMed ID: 31122866
[No Abstract] [Full Text] [Related]
23. Trastuzumab in combination with metronomic cyclophosphamide and methotrexate in patients with HER-2 positive metastatic breast cancer.
Orlando L; Cardillo A; Ghisini R; Rocca A; Balduzzi A; Torrisi R; Peruzzotti G; Goldhirsch A; Pietri E; Colleoni M
BMC Cancer; 2006 Sep; 6():225. PubMed ID: 16978400
[TBL] [Abstract][Full Text] [Related]
24. Pembrolizumab in hemodialysis patients. Is it safe?
Guzmán Vasquez M; Zapata Balcázar AP; Gaitán Tocora DG; Álamo Caballero C; Rodríguez Palomares JR; Sánchez Heras M; de Arriba de la Fuente G
Nefrologia (Engl Ed); 2020; 40(6):678-679. PubMed ID: 32354594
[No Abstract] [Full Text] [Related]
25. Transient acantholytic dermatosis in a patient with prostate cancer.
Khan MS; Khan M; Aivaz O
Dermatol Online J; 2020 Feb; 26(2):. PubMed ID: 32239889
[TBL] [Abstract][Full Text] [Related]
26. [A Patient with Lung Adenocarcinoma, Lymphangitis Carcinomatosa, and Multiple Bone Metastases Who Achieved Long-Term Survival after Successful Treatment with Carboplatin, Paclitaxel, and Bevacizumab].
Suzuki E; Tanahashi M; Yukiue H; Yoshii N; Shitara M; Fujino T; Niwa H
Gan To Kagaku Ryoho; 2016 May; 43(5):617-20. PubMed ID: 27210094
[TBL] [Abstract][Full Text] [Related]
27. Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial.
Vernieri C; Signorelli D; Galli G; Ganzinelli M; Moro M; Fabbri A; Tamborini E; Marabese M; Caiola E; Broggini M; Hollander L; Gallucci R; Vandoni G; Gavazzi C; Triulzi T; Colombo MP; Rizzo AM; Corsetto PA; Pruneri G; de Braud F; Sozzi G; Torri V; Garassino MC
Clin Lung Cancer; 2019 May; 20(3):e413-e417. PubMed ID: 30617039
[TBL] [Abstract][Full Text] [Related]
28. Phase 2 trial of neoadjuvant bevacizumab plus pemetrexed and carboplatin in patients with unresectable stage III lung adenocarcinoma (GASTO 1001).
Ou W; Li N; Wang SY; Li J; Liu QW; Huang QA; Wang BX
Cancer; 2016 Mar; 122(5):740-7. PubMed ID: 26700505
[TBL] [Abstract][Full Text] [Related]
29. Isolated Hypogonadotropic Hypogonadism Secondary to Anti-Programmed Death Ligand 1 Inhibitor.
Davies A; Naderpoor N; Parakh S
J Thorac Oncol; 2019 Jul; 14(7):e147-e148. PubMed ID: 31235040
[No Abstract] [Full Text] [Related]
30. Carboplatin, pemetrexed, and pembrolizumab was effective for primary salivary gland-type lung adenocarcinoma diagnosed due to esophageal stricture: A case report.
Kawakado K; Tamura T; Nakanishi M; Makimoto G; Sato Y; Kuyama S
Thorac Cancer; 2021 Sep; 12(18):2513-2516. PubMed ID: 34369074
[TBL] [Abstract][Full Text] [Related]
31. Cutaneous Toxicity After Chemoradiotherapy and PD-L1 Inhibition in Two Patients with Esophageal Adenocarcinoma: More than Meets the Eye.
van den Ende T; Menting SP; Ambarus CA; van Oijen MGH; van Laarhoven HWM
Oncologist; 2019 Apr; 24(4):e149-e153. PubMed ID: 30902915
[TBL] [Abstract][Full Text] [Related]
32. Intracranial Response to Nivolumab in a Patient with PD-L1-negative Lung Adenocarcinoma.
Nakahara Y; Fukui T; Shirasawa M; Harada S; Kusuhara S; Takakura A; Yokoba M; Mitsufuji H; Kubota M; Katagiri M; Sasaki J; Masuda N; Inukai M; Sekiguchi T; Naoki K
Intern Med; 2018 Nov; 57(21):3149-3152. PubMed ID: 29877291
[TBL] [Abstract][Full Text] [Related]
33. Pemetrexed as a component of first-, second- and third- line chemotherapy in treating patients with metastatic lung adenocarcinoma.
Huang XE; Tian GY; Cao J; Xu X; Lu YY; Wu XY; Liu J; Shi L; Xiang J
Asian Pac J Cancer Prev; 2014 Jan; 14(11):6663-7. PubMed ID: 24377585
[TBL] [Abstract][Full Text] [Related]
34. Frontline Systemic Therapy With Pemetrexed-Platinum in Nonsquamous Non-Small-Cell Lung Cancer With Asymptomatic Brain Metastases.
Alsidawi S; Chaudhary R; Karim NA
Am J Ther; 2017; 24(2):e111-e120. PubMed ID: 25153672
[TBL] [Abstract][Full Text] [Related]
35. PD-L1 Expression of Lung Cancer Cells, Unlike Infiltrating Immune Cells, Is Stable and Unaffected by Therapy During Brain Metastasis.
Téglási V; Pipek O; Lózsa R; Berta K; Szüts D; Harkó T; Vadász P; Rojkó L; Döme B; Bagó AG; Tímár J; Moldvay J; Szállási Z; Reiniger L
Clin Lung Cancer; 2019 Sep; 20(5):363-369.e2. PubMed ID: 31178388
[TBL] [Abstract][Full Text] [Related]
36. Nonenhancing brain metastases.
Karimi S; Lis E; Gilani S; D'Ambrosio N; Holodny A
J Neuroimaging; 2011 Apr; 21(2):184-7. PubMed ID: 19490401
[TBL] [Abstract][Full Text] [Related]
37. Multicenter phase II study of trastuzumab in combination with epirubicin and docetaxel as first-line treatment for HER2-overexpressing metastatic breast cancer.
Venturini M; Bighin C; Monfardini S; Cappuzzo F; Olmeo N; Durando A; Puglisi F; Nicoletto O; Lambiase A; Del Mastro L
Breast Cancer Res Treat; 2006 Jan; 95(1):45-53. PubMed ID: 16267615
[TBL] [Abstract][Full Text] [Related]
38. Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
Belani CP; Schreeder MT; Steis RG; Guidice RA; Marsland TA; Butler EH; Ramalingam SS
Cancer; 2008 Nov; 113(9):2512-7. PubMed ID: 18816622
[TBL] [Abstract][Full Text] [Related]
39. Disease Response with the Addition of Platinum-Based Chemotherapy to Pembrolizumab after Progression on Pembrolizumab Monotherapy in PD-L1-Expressing Non-Small Cell Lung Cancer.
Garcia CA; Dacic S; Villaruz LC
J Thorac Oncol; 2018 Aug; 13(8):e135-e136. PubMed ID: 30049372
[No Abstract] [Full Text] [Related]
40. A randomized phase 3 trial comparing pemetrexed/carboplatin and docetaxel/carboplatin as first-line treatment for advanced, nonsquamous non-small cell lung cancer.
Rodrigues-Pereira J; Kim JH; Magallanes M; Lee DH; Wang J; Ganju V; Martínez-Barrera L; Barraclough H; van Kooten M; Orlando M
J Thorac Oncol; 2011 Nov; 6(11):1907-14. PubMed ID: 22005471
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
